Structural Investigations of the Inhibition of Escherichia coli AmpC β-Lactamase by Diazabicyclooctanes

β-Lactam antibiotics are presently the most important treatments for infections by pathogenic Escherichia coli, but their use is increasingly compromised by β-lactamases, including the chromosomally encoded class C AmpC serine-β-lactamases (SBLs). The diazabicyclooctane (DBO) avibactam is a potent A...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Pauline A., Leissing, Thomas M., Page, Malcolm G. P., Schofield, Christopher J., Brem, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Mechanisms of Resistance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849013/
https://www.ncbi.nlm.nih.gov/pubmed/33199391
http://dx.doi.org/10.1128/AAC.02073-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849013/
https://www.ncbi.nlm.nih.gov/pubmed/33199391
http://dx.doi.org/10.1128/AAC.02073-20

Ejemplares similares